

CHICAGO TRIBUNE: Jeff Aronin of Marathon Pharmaceuticals on life after a $900M exit
After selling his pharmaceutical company, Ovation Pharmaceuticals, in 2009, Marathon Pharmaceuticals CEO Jeff Aronin sat down with the...


CHICAGO TRIBUNE: Duchenne muscular dystrophy drug could get OK for U.S. sales in 2016
The Chicago Tribune spoke to families and advocates seeking better treatment options for Duchenne muscular dystrophy as part of their...